Halozyme
S&P 400
$107.20
+0.19%
Delayed · cached 15 min
Frequently asked questions
What sector does Halozyme belong to?
Halozyme operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of HALO?
As of the latest available quote, HALO traded at $107.20. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of HALO?
Halozyme has a price-to-earnings (P/E) ratio of about 31.44. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of HALO?
The market capitalisation of Halozyme is approximately $13.27B.
Is Halozyme profitable?
For its latest reported financial year, Halozyme recorded a net profit margin of about 22.69%.
Does HALO pay a dividend?
Halozyme does not currently show a dividend yield in our data.
What is the return on equity (ROE) of HALO?
Halozyme has a return on equity (ROE) of about 220.76%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of HALO?
Over the past 52 weeks, HALO has traded between a low of $61.23 and a high of $111.15.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.